University of Dundee spinout MyWay Digital Health (MWDH) is set to receive a multimillion-pound deal from private investment firm Foresight.

Focusing on data-driven technology to support the management of long-term health conditions, with a particular focus on diabetes, Foresight’s investment will accelerate the firm’s development of new AI-enabled products.

Initial plans include work in predictive analytics and personalised care pathways, though the company will also expand its commercial footprint to meet growing global demand for scalable digital health solutions. 

MWDH’s flagship platform, MyWay Diabetes, is a clinically validated digital self-management tool that integrates with NHS systems to provide personalised education, data visualisation, and actionable insights for patients and clinicians. 

The platform has already been adopted across multiple NHS regions and internationally, demonstrating measurable improvements in patient engagement and health outcomes.

“We are delighted to have secured investment from Foresight, marking a significant milestone in MWDH’s journey,” said Debbie Wake, CEO and co-founder of MWDH. 

“Their support will enable us to accelerate our growth strategy, broaden our product offering, and further expand our global footprint.” 

Spun out of the University of Dundee in 2017, MWDH employs thirty staff across Dundee, Edinburgh, and London. 

The healthtech’s mission is to improve the lives of individuals living with long-term conditions through cost-effective, data-driven, personalised health technology, resulting in a suite of products that spans diabetes prevention, cardiovascular health, hypertension, and weight management.

Recommended reading

• How Much Did UK HealthTechs Raise Last Year?
• STAC Invest Backs Three Scottish Healthtech Innovators
• Edinburgh AI Healthtech Lands £3.6M Scottish Enterprise Boost

As well as this fresh investment, Dr Umang Patel will join as non-executive chair to support the company’s growth, working closely with the management team to drive both domestic and international expansion. 

Dr Patel brings experience from the technology and healthcare sectors and currently serves as chief clinical information officer for Microsoft in the EMEA region.

“The adoption of digital tools and AI to reduce the burden on frontline care is critical,” said Daniel Halliday, managing director at Foresight Group.

“MWDH is at the forefront of this, and its best-in-class technology is proven to deliver better health outcomes and cost savings for its customers. Foresight is excited to support the team on their next phase of growth.”